Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy

Autor: Larsen, Mathilde S., Bjerre, Karsten, Lykkesfeldt, Anne E., Giobbie-Hurder, Anita, Lænkholm, Anne-Vibeke, Henriksen, Katrine L., Ejlertsen, Bent, Rasmussen, Birgitte B.

Publikováno v: In The Breast October 2012 21(5):662-668

The Effect of 5-Bromodeoxyuridine on DNA Replication and Cell Division in Tetrahymena pyriformis

Autor: Lykkesfeldt, Anne E., Andersen, H. A.

Publikováno v: The Journal of Cell Biology, 1974 Aug 01. 62(2), 316-321.

Externí odkaz: https://www.jstor.org/stable/1607122

Correction:VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

Autor: Elias, D., Vever, Henriette, Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.

Publikováno v: Elias, D, Vever, H, Lænkholm, A V, Gjerstorff, M F, Yde, C W, Lykkesfeldt, A E & Ditzel, H J 2020, ' Correction : VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6) ', Oncogene, vol. 39, no. 10, pp. 2229-2230 . https://doi.org/10.1038/s41388-019-1096-8

Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::b051a8e3febdcb0bc7549e6995ab51da
https://findresearcher.sdu.dk:8443/ws/files/156519405/Correction.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to:Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

Autor: Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.

Publikováno v: Elias, D, Vever, H, Lænkholm, A V, Gjerstorff, M F, Yde, C W, Lykkesfeldt, A E & Ditzel, H J 2018, ' Correction to : Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138) ', Oncogene, vol. 37, no. 41, pp. 5585–5586 . https://doi.org/10.1038/s41388-018-0495-6

Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::0423a71859ac5b54355b59e1cccc56d5
https://findresearcher.sdu.dk:8443/ws/files/143489438/Correction_to_Gene_expression_profiling_identifies_FYN_as_an_important_molecule_in_tamoxifen_resistance_and_a_predictor_of_early_recurrence_in_patients_treated_with_endocrine_therapy.pdf